Catalyst Wire Dossier Catalyst Wire Dossier

KEYTRUDA

PEMBROLIZUMAB · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

675 regulatory and trial events tracked for KEYTRUDA, covering 2014-09-04 to 2026-07-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer [Phase 3]

See pricing